IHS Chemical Week

Regions :: Western Europe :: France

Rhodia Acquisition Underpins Solvay's Earnings and Sales

7:31 AM MST | February 16, 2012 | Sotirios Frantzanas

Solvay says net profits and net sales, on a proforma basis, increased 5% and 3% in the fourth quarter of 2011, to approximately €3 billion ($3.9 billion) and €122 million, respectively. Recurring Ebitda (Rebitda) and recurring Ebit (Rebit) on a proforma basis decreased 23% and 39% year over year, to €355 million and €184 million, respectively, Solvay says. The proforma basis presents Solvay's results as if last year's acquisition of Rhodia had become effective from January 1, 2010, the company says. It also harmonizes the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa